Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alx Oncology Holdings Inc (NQ: ALXO )

8.000 +0.550 (+7.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,944,121
Open 7.550
Bid (Size) 7.510 (1)
Ask (Size) 8.210 (2)
Prev. Close 7.450
Today's Range 7.260 - 8.110
52wk Range 5.820 - 81.19
Shares Outstanding 40,680,947
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Monday
Monday's session saw 84 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 36 companies achieved new lows for the year. 
Via Benzinga

Performance

YTD
-63.74%
-63.74%
1 Month
+1.27%
+1.27%
3 Month
-55.43%
-55.43%
6 Month
-64.22%
-64.22%
1 Year
-85.49%
-85.49%

More News

Read More
ALX Oncology's Evorpacept Gets Orphan Drug Tag For Gastric Cancer
Via Benzinga
ALX Oncology Holdings: Q4 Earnings Insights
Via Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
Via FinancialNewsMedia
Topics Death
Exposures Death
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Via Benzinga
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
Via Benzinga
58 Biggest Movers From Yesterday
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
75 Biggest Movers From Yesterday
Via Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
Via Benzinga
Zymeworks and ALX Oncology Announce First Patient Dosed in Phase 1b/2 Clinical Trial of Zanidatamab and Evorpacept (ALX148) in Patients with Advanced HER2-Expressing Breast Cancer and Other Solid Tumors
From Zymeworks Inc.
Via Business Wire
58 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
A Peek Into The Markets: US Stock Futures Climb Ahead Of GDP, Jobless Claims Data
Via Benzinga
Topics Stocks
Exposures US Equities
81 Biggest Movers From Yesterday
Via Benzinga
55 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
The 3 Best Biotech Stocks to Buy Right Now
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
Via Benzinga
Jon Najarian Sees Unusual Options Activity In Lucid Motors, Kura Oncology And More
Via Benzinga
So What's Going On With ALX Oncology's Stock?
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.